How Long Does Hydrocodone Last for Pain Relief?

Standard immediate-release hydrocodone provides pain relief for roughly four to six hours per dose, which is why prescriptions typically call for dosing every four to six hours as needed. Extended-release formulations stretch that window considerably, with some designed to maintain steady pain control for a full 24 hours on a single daily dose. But the actual duration you experience depends on more than which pill you take: your genetics, other medications, kidney and liver function, and even the time of day all play a role.

Immediate-Release Versus Extended-Release Formulations

Most hydrocodone prescriptions in the United States are for immediate-release combination products, such as hydrocodone paired with acetaminophen or ibuprofen. These formulations are absorbed relatively quickly, reach peak blood levels within about an hour or two, and are cleared fast enough that another dose is needed every four to six hours. That frequent dosing creates a roller-coaster pattern of blood levels: the drug concentration spikes after each dose and drops off before the next one, which can leave gaps in pain control.

Extended-release formulations were developed to smooth out that pattern. A once-daily extended-release hydrocodone tablet produces lower-fluctuating plasma concentrations compared to an immediate-release hydrocodone product taken every six hours, and pain control stays consistent over the full 24-hour dosing interval.1PubMed. Pharmacokinetic Profile and Sustained 24-hour Analgesia of a Once-daily Hydrocodone Bitartrate Extended-release Tablet with Abuse-deterrent Properties There are also biphasic formulations that combine an immediate-release and an extended-release component in a single tablet. These reach peak concentration faster than a pure extended-release product while maintaining a longer half-life than a pure immediate-release product, allowing dosing every 12 hours instead of every six. That means half as many concentration peaks and troughs throughout the day.2PubMed Central. Single- and multiple-dose pharmacokinetics of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) compared with immediate-release hydrocodone bitartrate/ibuprofen and immediate-release tramadol HCl/acetaminophen – Section: RESULTS

Extended-release capsules show dose-proportional behavior across a wide dosage range, meaning doubling the dose roughly doubles the drug exposure in the blood. Their absorption profiles vary from person to person, but effective concentrations are reached quickly enough for clinical use and maintained for a long period afterward.3PubMed. Population pharmacokinetic analysis for hydrocodone following the administration of hydrocodone bitartrate extended-release capsules – Section: CONCLUSIONS

Why the Same Dose Doesn’t Work the Same for Everyone

One of the more underappreciated facts about hydrocodone is that your liver’s enzyme activity has a major influence on how well the drug works, not just how long it lasts. Hydrocodone itself provides some pain relief, but a significant portion of its analgesic punch comes from an active metabolite called hydromorphone. The enzyme responsible for that conversion is called CYP2D6, and activity levels of this enzyme vary widely across the population based on genetics.4PubMed. CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone

People fall along a spectrum from “poor metabolizers,” who convert very little hydrocodone into hydromorphone, to “ultra-rapid metabolizers,” who convert it very efficiently. Poor and intermediate metabolizers may find that hydrocodone provides less pain relief at standard doses, not because the drug wears off faster but because they never produce enough of the active metabolite to get the full effect. A clinical trial found that when prescribers used genetic testing to guide opioid choice for intermediate and poor metabolizers, those patients saw meaningfully better pain improvement compared to patients who received the usual care without genetic guidance.5Genetics in Medicine. CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial – Section: Results

If you have ever felt that hydrocodone “doesn’t work” for you while it works fine for someone else at the same dose, genetics is one of the likeliest explanations. This isn’t an issue unique to hydrocodone; codeine and tramadol rely on the same enzyme pathway, which is why all three drugs tend to underperform in the same people.

Medications That Interfere with Hydrocodone’s Pain Relief

Even if your genetics are favorable, other medications can effectively block the CYP2D6 enzyme and mimic the effect of being a poor metabolizer. Common culprits include certain antidepressants, particularly SSRIs like paroxetine and fluoxetine, as well as some antihistamines like diphenhydramine. An emergency department study found that patients who had taken one or more CYP2D6-dependent medications in the 48 hours before receiving hydrocodone were only about a third as likely to respond to it as patients not taking those drugs.6PubMed Central. The Effect of CYP2D6 Drug-Drug Interactions on Hydrocodone Effectiveness – Section: Results

The interaction is specific to the metabolic pathway. When paroxetine was given alongside hydrocodone in a controlled study, the formation of hydromorphone dropped dramatically while the parent hydrocodone levels stayed about the same. Separately, ritonavir, an antiviral drug used in HIV treatment that inhibits a different liver enzyme (CYP3A4), increased overall hydrocodone exposure by roughly 90% based on the area-under-the-curve measurement.7PubMed Central. Hydrocodone, Oxycodone, and Morphine Metabolism and Drug–Drug Interactions – Section: Results That second interaction works in the opposite direction: instead of reducing pain relief, it raises hydrocodone levels high enough to increase the risk of side effects. Either way, other medications can meaningfully change how long and how well hydrocodone controls your pain.

How Food Changes the Timing

Taking an extended-release hydrocodone tablet with food versus on an empty stomach doesn’t dramatically change how much drug your body absorbs overall, but it does shift the timing. In a study of healthy volunteers given a 20 mg extended-release hydrocodone tablet, the total absorption was comparable in fed and fasted states. However, peak blood concentration was higher when taken with food (about 29 ng/mL versus 23 ng/mL), and it arrived sooner: around six hours in the fed state compared to about eight hours in the fasted state. The half-life was also somewhat shorter with food, roughly five hours versus six and a half hours.8PubMed Central. Effects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteers – Section: Results

In practical terms, eating before taking the medication may help you feel relief slightly sooner, with a somewhat higher peak. But the overall amount of drug absorbed stays about the same. This is relevant mainly for extended-release formulations; with immediate-release products, the absorption window is already short enough that food plays a smaller role.

Kidney Disease, Liver Disease, and Older Adults

Your kidneys and liver both matter for how long hydrocodone stays active in your body. Hydrocodone and its metabolites accumulate in people with impaired kidney function. In pharmacokinetic studies, people with moderate to severe kidney impairment showed systemic drug exposure up to about 70% higher than people with normal kidney function.9PubMed. Effects of Renal Impairment and Hepatic Impairment on the Pharmacokinetics of Hydrocodone After Administration of a Hydrocodone Extended-Release Tablet Formulated With Abuse-Deterrence Technology For older adults with chronic kidney disease, clinical guidance recommends starting at the lowest possible dose, around 2.5 to 5 mg every four to six hours, with careful monitoring for side effects like drowsiness, nausea, and dizziness.10PubMed Central. Opioid Management in Older Adults with Chronic Kidney Disease: A Review – Section: Safe Prescribing Practices for Opioid Use in Older Adults with Chronic Kidney Disease

Liver impairment follows a similar pattern. People with moderate hepatic impairment showed roughly 70% higher drug exposure compared to people with normal liver function.9PubMed. Effects of Renal Impairment and Hepatic Impairment on the Pharmacokinetics of Hydrocodone After Administration of a Hydrocodone Extended-Release Tablet Formulated With Abuse-Deterrence Technology In patients with severe liver disease, the recommendation is to cut the initial dose by half, and even for those with less advanced liver problems, spacing doses further apart is generally advised.11Hepatitis Monthly. Opioid Drugs in Patients With Liver Disease: A Systematic Review – Section: Hydrocodone, Hydromorphone Higher drug exposure means each dose effectively lasts longer, but it also means side effects and toxicity risks climb. For these populations, the question isn’t really “how long does it last?” but “how do I avoid it lasting too long?”

Children Clear Hydrocodone Faster Than Adults

Pediatric dosing is a different picture entirely. A pharmacokinetic study in children aged 6 to 17 found that their weight-adjusted clearance of hydrocodone was about 42% higher than in healthy adults.12PubMed. Pharmacokinetics of hydrocodone/acetaminophen combination product in children ages 6-17 with moderate to moderately severe postoperative pain Faster clearance means the drug leaves the body sooner, which in turn means a given milligram-per-kilogram dose produces less total drug exposure than the same weight-based dose in an adult. This doesn’t necessarily mean children need more frequent dosing; it means that pediatric dosing requires its own calibration rather than simply scaling down an adult dose.

How Hydrocodone Stacks Up Against Oxycodone

Hydrocodone and oxycodone are the two most commonly prescribed opioids in the United States, and patients frequently wonder whether one lasts longer or works better. In a double-blind trial of emergency department patients with acute fracture pain, both drugs provided meaningful pain relief within 30 minutes and continued to provide relief through 60 minutes, with no significant difference in pain scores between the two groups at either time point.13PubMed. Comparison of oxycodone and hydrocodone for the treatment of acute pain associated with fractures: a double-blind, randomized, controlled trial – Section: RESULTS The immediate-release forms of both drugs have similar durations of action, typically four to six hours.

One difference worth knowing: oxycodone does not rely on CYP2D6 to the same extent for its analgesic effect. The same emergency department study that found CYP2D6-inhibiting drugs dramatically reduced hydrocodone’s effectiveness found no significant difference in oxycodone effectiveness based on CYP2D6 status.6PubMed Central. The Effect of CYP2D6 Drug-Drug Interactions on Hydrocodone Effectiveness – Section: Results So while both drugs produce comparable pain relief in a general population, oxycodone may be a more reliable choice for people who take medications that interfere with CYP2D6 or who are known poor metabolizers.

Time of Day May Affect How Well Opioids Work

This one surprises most people: pain sensitivity and opioid effectiveness both appear to fluctuate over the course of a 24-hour day. Research on biological rhythms and pain has consistently found that pain intensity varies according to the time of day in patients with various conditions, and the effectiveness of opioid analgesics tracks a daily rhythm as well, though the timing of peak and low effects differs between studies and drugs.14Pharmacology & Therapeutics. Biological rhythms in pain and in the effects of opioid analgesics

A study in healthy volunteers that examined fentanyl (a different opioid, but one that shares key receptor pathways with hydrocodone) found significant time-related variations in both peak analgesic effect and duration of effect. The least analgesic effect occurred during the early morning hours, around 2 a.m., and the shortest duration of pain relief was observed around 8 a.m.15PubMed Central. Opioid chronopharmacology: influence of timing of infusion on fentanyl’s analgesic efficacy in healthy human volunteers – Section: Results Whether hydrocodone follows the same daily rhythm hasn’t been studied with the same specificity, but the underlying biology of opioid receptors and pain pathways is shared. If you notice that your pain medication seems less effective at certain times of day, this circadian variation is a plausible contributor, and it may be worth discussing dose timing with your prescriber.

Why Hydrocodone Seems to Stop Working Over Time

Anyone who has taken hydrocodone for more than a few weeks has likely noticed that the same dose gradually provides less relief. This is opioid tolerance, a well-documented phenomenon where the body’s opioid receptors adjust to the continuous presence of the drug. The receptors become less responsive, and what once provided four to six hours of relief may start to feel like it fades after two or three. Tolerance doesn’t mean the drug is being eliminated faster; it means the brain is requiring a larger signal to achieve the same effect.

Tolerance develops at different rates for different opioid effects. Pain relief tolerance often develops faster than tolerance to some side effects, such as constipation, which can persist even as the analgesic benefit fades. This creates a frustrating situation where you may feel you need a higher dose for pain but are still dealing with side effects at the current dose. Tolerance is one of the primary reasons that opioids, including hydrocodone, are generally recommended for short-term use whenever possible and why long-term use involves periodic reassessment of whether the drug is still providing a net benefit.

Abuse-Deterrent Formulations and How They Affect Absorption

Extended-release hydrocodone products increasingly incorporate abuse-deterrent technology designed to resist crushing, dissolving, or snorting. These features aren’t just about preventing misuse; they also change the drug’s absorption profile in ways that are relevant to legitimate patients. When an abuse-deterrent extended-release hydrocodone tablet was tested via nasal administration (the route favored in misuse), the peak concentration was dramatically lower and the time to peak was more than double compared to hydrocodone powder without the deterrent technology.16PubMed Central. Intranasal Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users – Section: RESULTS

For patients taking the medication as prescribed by mouth, the abuse-deterrent features generally don’t change the duration of pain relief. But they’re worth knowing about because they explain why these tablets shouldn’t be crushed, split, or chewed. Doing so can defeat the extended-release mechanism and dump the full dose at once, which defeats the purpose of steady, prolonged pain control and introduces real safety risks. If you have trouble swallowing tablets, talk to your prescriber about alternative formulations rather than altering the tablet yourself.

Francesca Lindsay

Francesca Lindsay has spent 16 years as a clinical pharmacist in internal medicine at an academic medical center. She earned her PharmD at the UNC Eshelman School of Pharmacy, completed a PGY-1 residency and is a Board Certified Pharmacotherapy Specialist. Her clinical focus is dosing and adverse drug reactions in complex patients.